By Carlo Martuscelli

 

Merck KGaA said Tuesday that it has signed a contract to manufacture liquid biopsy kits for Swedish diagnostics business Elypta.

The kits will be used to detect biological markers for cancer, the German company said.

 

Write to Carlo Martuscelli at carlo.martuscelli@wsj.com; @carlomartu

 

(END) Dow Jones Newswires

February 18, 2020 08:37 ET (13:37 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more Merck KGaA (PK) Charts.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more Merck KGaA (PK) Charts.